Impact of spatial proximity on territoriality among human skin bacteria


Bacteria display social behavior and establish cooperative or competitive interactions in the niches they occupy. The human skin is a densely populated environment where many bacterial species live. Thus, bacterial inhabitants are expected to find a balance in these interactions, which eventually defines their spatial distribution and the composition of our skin microbiota. Unraveling the physiological basis of the interactions between bacterial species in organized environments requires reductionist analyses using functionally relevant species. Here, we study the interaction between two members of our skin microbiota, Bacillus subtilis and Staphylococcus epidermidis. We show that B. subtilis actively responds to the presence of S. epidermidis in its proximity by two strategies: antimicrobial production and development of a subpopulation with migratory response. The initial response of B. subtilis is production of chlorotetain, which degrades the S. epidermidis at the colony level. Next, a subpopulation of B. subtilis motile cells emerges. Remarkably this subpopulation slides towards the remaining S. epidermidis colony and engulfs it. A slow response back from S. epidermidis cells give origin to resistant cells that prevent both attacks from B. subtilis. We hypothesized that this niche conquering and back-down response from B. subtilis and S. epidermidis, respectively, which resembles other conflicts in nature as the ones observed in animals, may play a role in defining the presence of certain bacterial species in the specific microenvironments that these bacteria occupy on our skin.


Diverse populations of human-associated bacteria live on the skin and are harmless or beneficial to their human host1. Symbiotic bacteria occupy skin niches and protect against colonization by pathogenic bacteria2. For example, Bacillus subtilis is known to protect the skin by producing bacitracin, a compound that inhibits the growth of other bacteria3,4. Although extensive research on the influence of the skin bacteria in the skin health has been performed5,6, few studies have investigated the specific interactions between members of the skin microbiota. The elucidation of these interactions is necessary to understand the complex organization of microbial communities e.g., the human microbiota.

Since the skin surface is a nutrient-poor niche1, microbial species are likely to compete for resources and colonization. The outcome of this microbial competition is the delicate balance in the diversity of bacterial species that inhabit our skin7,8. Bacteria employ different chemical and physical mechanisms to harm, inhibit or kill their competitors9. Chemical mechanisms include secretion of broad-spectrum antibiotics10 or strain-specific bacteriocins11, whereas physical mechanisms such as adhesion12 or secretion of polymeric substances13 allow bacteria to interfere with the growth of others. Here we study the potential interactions among Bacillus subtilis and Staphylococcus epidermidis. Both bacterial species are inhabitants of the same ecological niche, the human skin.

B. subtilis is a relevant member of the human microbiota. This bacterium produces and secretes several molecules to control the growth of other bacteria14, probably as an adaptive strategy to subsist in the densely populated environments where it is found (skin, digestive tract, extremities of human body and soil)7,15,16. B. subtilis is the second most frequently associated bacteria in neonates17. In addition, in healthy individuals (including adults) it has been found in the outer ear skin17, and it is predominately found in the plantar skin of humans with strong foot odor18. S. epidermidis is a major inhabitant of the skin, and comprises more than 90% of the aerobic resident microbiota2. Despite the innocuous nature of S. epidermidis, this bacterium is currently seen as an important opportunistic pathogen in patients receiving medical devices19. S. epidermidis is one of the most frequent nosocomial infections, and in particular it is involved in the infection of catheters and implants19,20.

Recent studies show that bacteria form biofilms in response to ecological competition21. In this respect, Bacillus subtilis is a master in cell differentiation and several subpopulations of functionally distinct cell types coexist within its biofilms22. Besides biofilm formation, B. subtilis is a model for motility of Gram-positive bacteria; it is able to swim, swarm and slide23,24. The use of flagella allows the bacterium to swim and swarm, but the flagellum-independent sliding occurs due to growth25. Sliding is a poorly understood process, but it is known to depend upon multiple factors, such as the production of surfactin and/or the extracellular proteins BslA and TasA25,26,27.

Here, we study the B. subtilis antimicrobial production and sliding motility in response to the presence of S. epidermidis. Bacterial colonies are able to interact at a close proximity, and by using a colony model we simulate the interactions between bacterial communities. Firstly, we start our analysis by visualizing the B. subtilis production of antimicrobials, which inhibit the growth of S. epidermidis. Cells of the attacked S. epidermidis colony rapidly develop resistance and give rise to resistant colonies. The traditional approach to study antimicrobials is based on the extraction of the compounds from culture supernatants, followed by screening of fractions to identify the inhibitory molecules28. Bacterial competition approaches, where two bacteria are co-cultured, allow us to revisit the mechanisms involved in competitive interactions between bacteria29. In this respect, genomic DNA sequencing of S. epidermidis resistant colonies revealed a point-nonsense mutation in the gene encoding the di-peptide transport system (DtpT) and several mutations in the gene encoding the biofilm-associated protein (Bap). Interestingly, bacilysin, the simplest peptide antibiotic known, is such a dipeptide synthesized by B. subtilis30. We demonstrate that B. subtilis produces chlorotetain, a halogenated variant of bacilysin, which kills S. epidermidis cells. Secondly, after the chemical attack, motile B. subtilis emerges from the colony to dramatically engulf the wild-type S. epidermidis colony. This migratory response is not developed towards the S. epidermidis resistant colonies. Therefore, our results suggest that functional Bap proteins indirectly trigger the motility of B. subtilis. Lastly, we show that the response regulator DegU regulates the behavior phenomena exhibited by B. subtilis, and it appears to mediate the interaction between B. subtilis and S. epidermidis.


Interaction between B. subtilis and S. epidermidis colonies

We start by analyzing whether B. subtilis and S. epidermidis are able to interact at the colony level, using a chemically defined medium (CDM) to simulate the interactions among bacterial communities in poor-nutrient niches. To assess the interaction between colonies, both bacteria are spotted on a CDM-agar plate at different separation distances. This interaction assay shows that the colonies are able to interact at a close proximity, resulting in growth inhibition of S. epidermidis (Fig. 1). The shorter the distance between colonies, the higher the growth inhibition effect on the S. epidermidis colony. Notably, B. subtilis develops an active migratory response towards S. epidermidis. At the closest proximity, B. subtilis cells are able to engulf the colony of S. epidermidis. The growth inhibition and migratory response phenomena are not observed when each species is independently grown (Fig. S1). Moreover, we tested the interaction between B. subtilis with another skin bacterium (Cutibacterium brevis) and with other Gram-positive bacteria (Lactococcus lactis and Streptococcus thermophilus), and noted that the colony degradation only occurred against S. epidermidis (Fig. S2a). We observed the colony engulfment capacity of B. subtilis to other bacteria, as reported in a previous study on the interactions between different Bacillus species31. Interestingly, in an interaction assay between B. subtilis, S. epidermidis and L. lactis (Fig. S2b), B. subtilis specifically responds only to the presence of S. epidermidis. This result suggests that only B. subtilis and S. epidermidis appear to establish this specific interaction (antimicrobial production and motility) at the colony level.

Fig. 1: B. subtilis antimicrobial production and sliding in the proximity of S. epidermidis.

a Interaction assay of bacterial colonies of B. subtilis (B) and S. epidermidis (S) at different separation distances on CDM-agar plates, after 28 h incubation at 37 °C. Snapshots of microscope observations bright field are shown. Scale bar, 1 mm. b Interaction between bacterial colonies at different incubation times. A B. subtilis GFP+ (B) and S. epidermidis GFP− (S) are shown. Snapshots of observations by fluorescence microscopy are shown. Scale bar, 1 mm. c, B. subtilis motility in CDM-agar plates with varying concentrations of agar (0.8, 1, 1.5, and 2%). Observations after 24 h incubation (top images) of a T-shape interaction assay where B. subtilis (colonies located at the horizontal line) and S. epidermidis (colonies located at the vertical line) are shown. Observations after 48 h incubation highlight the B. subtilis (B) motility towards S. epidermidis (S). Snapshots of observations by fluorescence microscopy are shown. Scale bar, 1 mm.

Next, we examine the time it takes to observe both responses. To distinguish the growth of B. subtilis from S. epidermidis, we used a green fluorescent protein (GFP)-marked B. subtilis strain. Figure 1b shows that the inhibitory growth effect occurs rapidly and is clearly visible at the end of 24 h of incubation, whereas the B. subtilis motility is a progressive response completed after 48 to 72 h of incubation. To this end, we aimed to distinguish the B. subtilis motility strategy. Swimming, swarming and sliding are the three motility strategies employed by B. subtilis32. Since an agar concentration below 1.5% (w/v) in CDM-agar plates allow B. subtilis to swim and swarm, Fig. 1c shows that 48 h of incubation, B. subtilis is able to display motility towards S. epidermidis at even an agar concentration of 2% (w/v). With respect to the growth inhibition effect on S. epidermidis, the varying concentrations of agar in the growth medium did not change the inhibitory effect. These findings suggest that B. subtilis is able to attack S. epidermidis in two phases, the first phase involves antimicrobial production, and the second phase consists of mobilization of cells via sliding to engulf the neighbor colony.

Genetic elements involved in the B. subtilis sliding response

B. subtilis motility has been extensively studied, and its transcriptional and post-transcriptional regulation have been described in detail23,25,32. The master regulator DegU, known to control the production of extracellular enzymes such as the bacillopeptidase (encoded by the bpr gene)33, also coordinates motility34, colony architecture35 and cell differentiation36. Biofilm formation, and flagellum and non-flagellum dependent motility are regulated by the transcription factor SinR37. The B. subtilis biofilm consists of cells attached to each other by an extracellular matrix, and the production of the matrix occurs in cells with inhibited flagellar motility22. The flagellar filament protein that provides the origin to the flagellum is encoded by the hag gene, and the extracellular matrix production is encoded by the epsE-O operon to produce exopolysaccharides (EPS) while the major protein component of the matrix, TasA, is encoded by the yqxM-sipW-tasA operon38. Despite the fact that sliding motility does not depend on a flagellum, it does depend on surfactin (encoded by the srfA gene), EPS, and extracellular proteins such as the biofilm-surface layer protein A (BslA) and TasA25.

To identify the genetic requirements for motility, we aimed to test whether a specific process, e.g., motility, matrix production or surfactin production occurs in the B. subtilis migratory cells during the interaction assay. To this end, we evaluated the green fluorescent protein (GFP) expression in colonies of our interaction assay. We used B. subtilis strains bearing transcriptional fusions of several gene promoters with the gfp gene. Figure 2a shows that both the migratory cells and the B. subtilis colony activate the promoters controlling the expression of surfactin (srfA), flagellin (hag), bacillopeptidase (brp) and the BslA protein (bslA). Therefore, we investigated their expression at the single-cell level, after dispersing the biofilms, by using flow cytometry (see “Methods” section). Figure 2b shows the percentages of cells with srfA, hag, brp, bslA expression, compared to the B. subtilis wild type (B-WT), as single colonies (left) and in the interaction assays against S. epidermidis (right), at three sampling points (24, 48, and 72 h). The single-cell measurements allowed us to identify two highly activated subpopulations: motile B. subtilis cells (hag) and surfactin-secreting (srfA) cells (Fig. S3). This result indicates that these B. subtilis subpopulations underline the bacterial interaction against S. epidermidis. For instance, we observe that at an early incubation time (24 h), hag is highly expressed (65% in the interaction assay), whereas at late incubation time (72 h), surfactin (srfA, highly expressed in 91% cells of the interaction assay) plays an important role. Our data is in agreement with the observation of complete engulfment of the S. epidermidis colony after 72 h incubation in our interaction assays.

Fig. 2: Genetic elements of B. subtilis involved on its antimicrobial and motility response.

aB. subtilis (B) strains bearing transcription fusions of promoters (PsrfA, Phag, PbslA, Pbpr) with the gene encoding the green fluorescent protein (gfp) in interaction assays against S. epidermidis (S). Snapshots of colonies on CDM-agar plates incubated at 37 °C for 72 h. Scale bar, 1 mm. b Single-cell fluorescence measurements by flow cytometry, in the B. subtilis (B) strains bearing transcription fusions of promoters (PsrfA, Phag, PbslA, Pbpr) with the gene encoding the green fluorescent protein (gfp) in single colonies (left) and interaction assays against S. epidermidis (S; right), at different incubation times (24, 48, and 72 h). The percentage of cells with higher gene expression above the background fluorescence level (above the B-WT fluorescence; indicated with a gray window) is shown. 30,000 ungated events for each sample are shown. cB. subtilis deletion mutants (tasA, epsG, srfA, hag, degU, and sinR) in in interaction assays against S. epidermidis (S). Snapshots of colonies on CDM-agar plates incubated at 37 °C for 48 h. Scale bar, 1 mm.

Next, we tested the migratory response of B. subtilis deletion mutants of key genes involved in motility, matrix production and motility. Figure 2b shows the effect of strains affected in the production of the extracellular matrix (TasA, EPS) on motility and antimicrobial production. A slight defect in migratory response for the epsG mutant, and no motility defects are observed for the tasA mutant. With respect to surfactin, the deletion of srfA results in a low motility response. Remarkably, the hag mutant shows a reduced migratory response (Fig. 2c and Fig. S4), and since sliding represents a flagellum-independent motility, this result confirms that B. subtilis employs sliding motility in our interaction assays. We also evaluated the deletion mutants of the main regulators DegU and SinR. Importantly, the lack of DegU results in a lack of antimicrobial production and absence of the migratory response (Fig. 2c and S5). In contrast, the lack of SinR results in antimicrobial production, but no migratory response. Previous studies conclude that SinR is a regulator that controls the transition between motile and non-motile cells in order to form multicellular communities39.

As noted in Fig. 2a, the production of the extracellular enzyme bacillopeptidase (bpr) does not play a role in this bacterial interaction. We further studied the role of extracellular enzymes by using B. subtilis WB800, an eight protease-deficient strain (nprE, nprB, aprE, epr, bpr, mpr, vpr, wprA)40. Fig. S6 shows that B. subtilis WB800 is able to degrade the S. epidermidis colony. Therefore, we discarded the possibility that the extracellular proteases are responsible for the S. epidermidis colony degradation.

Together, these findings show that B. subtilis develops sliding motility, involving motile cells (hag) and surfactin-expressing cells (srfA), to reach and surround S. epidermidis. The regulator SinR coordinates this process. In addition, the master regulator DegU not only participates in controlling the motility response, but also in the antimicrobial production against S. epidermidis.

Development of antimicrobial resistance in S. epidermidis

Next, we performed an interaction assay where B. subtilis and S. epidermidis colonies have a separation distance that does not allow B. subtilis to slide and reach the neighbor colony, but it does allow the antimicrobial compound produced by B. subtilis to diffuse and degrade (part of) the neighbor colony. Resistant cells of S. epidermidis emerge and give rise to bacterial colonies after six days of incubation. Figure 3a shows several resistant colonies, and four of them (indicated with numbers) were selected to gain insight into the nature of the antimicrobial compound secreted by B. subtilis. Next, we confirmed the resistance of the selected S. epidermidis strains in an interaction assay against B. subtilis. Figure 3b shows that the highest antimicrobial resistance is observed in the strains 1 (S-1) and 3 (S-3), whereas the strains 2 (S-2) and 4 (S-4) are partially resistant compared to the wild type (S-WT). To investigate whether genetic mutations are responsible of the resistant phenotype, the genomes of S-1 and S-3 were sequenced. The genomic sequence data reveals that these strains have mutations located in only two coding genes, i.e., a point non-sense mutation in the dtpT gene encoding the dipeptide transport system DtpT and several mutations in the bap gene encoding the biofilm-associated protein Bap. Remarkably, the mutation in dtpT causes a non functional dipeptide transport system. Therefore, this finding suggests that a dipeptide with antimicrobial activity is produced by B. subtilis against S. epidermidis.

Fig. 3: S. epidermidis resistant colonies emerge.

a Interaction assay of B. subtilis (B) and S. epidermidis (S) colonies on CDM-agar plates incubated at 37 °C for 6 days. Resistant colonies selected are indicated with numbers (1 to 4). Snapshots of observations with bright-field (left) and fluorescence (right) microscopy are shown. Scale bar, 1 mm. b Interaction assay with B. subtilis wild type strain (B) and S. epidermidis wild type (S-WT) and selected mutants (S-1, S-2, S-3, and S-4). Snapshots of observations with fluorescence microscopy are shown. Scale bar, 1 mm. c Mutations in the genomic sequence of both S. epidermidis S-1 and S-3 strains. Location and description of mutations in the dtpT and bap genes are indicated.

Chlorotetain production and genetic regulation

Previous studies on non-ribosomal peptides (NRPs) produced by B. subtilis have shown that this bacterium is able to secrete bacilysin (also known as tetaine) and its chlorinated derivatives bromotetain and chlorotetain14. Bacilysin is the simplest antibiotic known, made up of L-alanine and L-anticapsin30. This dipeptide is active against bacteria and some fungi like Candida albicans41. It is transported into the host cells, and its hydrolyzation by peptidases releases the L-anticapsin, which inhibits the glucosamine 6-phosphate (GlcN6P) synthase, resulting in cell death30,42. Interestingly, DegU was shown to positively regulate the biosynthesis of bacilysin in Bacillus amyloliquefaciens43. DegU and the DegS kinase are a two component signal system that controls several cellular processes, including motility and biofilm formation44. Thus, we tested a degU deletion mutant in the interaction assay against S. epidermidis. Figure 4a shows that the lack of DegU results in very low levels of S. epidermidis colony degradation, compared to the interaction with wild-type B. subtilis. Moreover, overnight B. subtilis bacterial supernatants of both wild type and ΔdegU strains were tested for antimicrobial production using S. epidermidis as indicator strain (Fig. 4b). Accordingly, the supernatant of the ΔdegU strain shows no antimicrobial activity. We performed ultra high-performance liquid chromatography coupled with mass spectrometry (UHPLC-M) to identify the chemical structure of the antimicrobial compound. The differential analysis of the compounds present in both bacterial supernatants (wild type and ΔdegU; Fig. 4c, d, respectively) clearly shows that the wild-type strain secretes the bacilysin derivative, chlorotetain (Fig. 4c). This result is in contrast to the supernatant of the ΔdegU strain, which does not contain chlorotetain (Fig. 4d). Chlorotetain is detected at 0.8273 min with m/z = 289.09 ([M + H]+).

Fig. 4: Chlorotetain production by B. subtilis.

a Interaction assay between B. subtilis wild type (B-WT) and S. epidermidis wild type (S) strains (top image), and between B. subtilis degU deletion mutant (B-ΔdegU) and S. epidermidis wild type (S) strains (bottom image). Snapshots of colonies on CDM-agar plates incubated at 37 °C for 24 h. Scale bar, 1 mm. b Antimicrobial activity of overnight bacterial supernatants of B. subtilis wild type (B-WT; left) and B. subtilis degU deletion mutant (B-ΔdegU) strains on CDM-agar plates. S. epidermidis wild type strain was used as indicator strain. A snapshot of the antimicrobial activity, indicated by the S. epidermidis growth inhibition halo, was taken after incubation at 37 °C for 24 h. Scale bar, 15 mm. c, d UHPLC chromatograms (top, x-axis indicates time in minutes, and y-axis indicates percentage of signal intensity) and mass spectra (bottom, x-axis indicates m/z, mass-to-charge ratio; and y-axis indicates percentage of signal intensity), respectively, to confirm the presence of chlorotetain in overnight bacterial supernatants of B. subtilis wild type (c) and B. subtilis degU deletion mutant d. The molecular weight of the peak of the mass spectrum in c corresponds to chlorotetain. e, chemical structures of bacilysin (left) and chlorotetain (right), the molecular weight and chemical formula is indicated.

The enzymes participating in the synthesis of bacilysin are encoded in the bacABCDE (ywfBCDEF) gene cluster of B. subtilis45. We aimed to confirm that bacilysin is solely responsible for the S. epidermidis colony degradation. To this end, we performed an interaction assay with two bacilysin mutant strains (B. subtilis ΔbacA and ΔbacD). Figure 5a shows that the bacilysin mutants are unable to degrade the S. epidermidis colony. In addition, the bacterial supernatant of any of bacilysin mutants shows no antimicrobial activity compared to the growth inhibition by the supernatant of the wild-type B. subtilis (B-WT) strain (Fig. 5b). Altogether, these results confirm that chlorotetain is solely responsible for the S. epidermidis colony degradation.

Fig. 5: Genetic elements involved in chlorotetain production by B. subtilis.

a Interaction assay between bacilysin B. subtilis mutants (B-ΔbacA and B-ΔbacD) with the wild-type S. epidermidis (S) strain, top and bottom images, respectively. Snapshots of colonies on CDM-agar plates incubated at 37 °C for 24 h. Scale bar, 1 mm. b Antimicrobial activity of overnight bacterial supernatants of the bacilysin B. subtilis mutant (B-ΔbacA and B-ΔbacD) and wild-type B. subtilis (B-WT) strains on CDM-agar plates. S. epidermidis wild-type strain was used as indicator strain. CDM, used for bacterial growth, is shown as a negative control. Snapshot of the antimicrobial activity, indicated by the S. epidermidis growth inhibition halo, was taken after incubation at 37 °C for 24 h. Scale bar, 10 mm. c Proposed model (top) of the relationship between the phosphorylation of DegU (highlighted with different thickness in the arrow), and its effect on bacilysin biosynthesis. Corresponding interaction assays (bottom) between B. subtilis degU mutants (B-degU32 and B-degU146; center and right, respectively) strains targeting the DegU phosphorylation levels and S. epidermidis wild type (S) strain. An interaction assay between wild-type strains of B. subtilis (B-WT) and S. epidermidis (S) was used as a control (left). Snapshots of colonies on CDM-agar plates incubated at 37 °C for 24 h. Scale bar, 1 mm. d, UHPLC chromatograms (top, x-axis indicates time in minutes, and y-axis indicates percentage of signal intensity) and mass spectra (bottom, x-axis indicates m/z, mass-to-charge ratio; and y-axis indicates percentage of signal intensity), respectively, to confirm the concentration levels of chlorotetain in overnight bacterial supernatants of B. subtilis degU mutants (B-degU32 and B-degU146; center and right, respectively) compared to the B. subtilis wild type (left). The molecular weight (289.09 g mol−1) of the peaks of the mass spectra corresponds to chlorotetain.

The gene regulation by DegU is dependent on its phosphorylation (DegU-P) by the DegS kinase36. Both forms of DegU, phosphorylated and non-phosphorylated, control different cellular processes. For instance the extracellular production of degradative enzymes requires high levels of DegU-P44. A previous study on bacilysin biosynthesis by B. amyloliquefaciens shows that both DegU and DegU-P are able to bind the bacABCDE operon promoter to produce bacilysin43. Based on this evidence, we next analyzed the contribution of DegU and DegU-P to the production of bacilysin in vivo. To achieve this aim, we used two B. subtilis strains with different phosphorylation levels of DegU. The degU32 mutant has been reported to show high levels of the phosphorylated form of DegU (DegU-P), whereas the degU146 mutant shows low levels of DegU-P46. We used these degU mutant strains in the interaction assay. Figure 5c shows increased bacilysin production by the B. subtilis degU32 mutant and reduced bacilysin production by the degU146 mutant. In addition, we identified the presence and concentration levels of chlorotetain in bacterial supernatants of the degU mutants by UHPLC-M. Figure 5d shows that the degU32 strain produces chlorotetain at higher concentrations than the wild type (B-WT), whereas chlorotetain is not detected in the bacterial supernatant of the deg146 strain. Altogether, we propose a model where DegU-P promotes bacilysin production by B. subtilis, and higher or lower levels of DegU phosphorylation result in increased or reduced bacilysin production, respectively.

Cell-to-cell attachment indirectly triggers motility

Regarding the factors involved in the S. epidermidis triggered B. subtilis motility, we investigated whether the intracellular or extracellular content of S. epidermidis cells promote the B. subtilis motility. To this end, we evaluated the intracellular and extracellular content of S. epidermidis cells in a disc assay (Fig. S7) and observed that the extracellular content triggers the B. subtilis motility.

As mentioned above, S. epidermidis S-1 and S-3 are not only resistant to chlorotetain, but also do not promote motility by B. subtilis. Therefore, we tested whether overnight S. epidermidis supernatants (S-WT, S-1, and S-3) are able to promote motility by B. subtilis. To this end, B. subtilis cells were spotted in a spiral configuration to show that colonies in the proximity to the supernatant are able to show the typical migratory response. Figure 6a shows that B. subtilis colonies (indicated with a B letter) exclusively develop motile cells towards the S. epidermidis S-WT supernatant located in the center of the agar plate (indicated with the letter S), compared to the control (CDM indicated with the letter C) and the S-1 or S-3 supernatant. A very low level of B. subtilis motility, at the closest distance to the supernatant, is slightly observed towards the S-1 supernatant. Figure 3c shows that the mutations in the biofilm-associated protein are located in a narrow range of residues of the protein sequence (981–1013). Thus, we analyze the Bap protein sequence in order to identify protein domains and gain an insight into the consequences of the mutations on the phenotype of the S-1 and S-3 strains. The sequence analysis reveals that the mutations target a cadherin repeat-like domain (Fig. 6b). Bap proteins are involved in attachment of cells to surfaces and intercellular adhesion. Previous studies show that Bap can sense the bacterial environment through Ca2+ concentration changes and trigger the cell-to-cell attachment or biofilm formation47. Indeed, cadherin repeat-like motifs are potential Ca2+ binding motifs48.

Fig. 6: Effects of mutations in the S. epidermidis biofilm-associated protein (Bap).

a Motility assay of B. subtilis (B) to the presence of bacterial supernatants of overnight cultures of S. epidermidis (S): wild-type (S-WT), and mutants (S-1 and S-3). CDM was used as a control (C; left). Snapshots of colonies on CDM-agar plates incubated at 37 °C for 24 h. Scale bar, 1 mm. b Identification of protein domains in the biofilm-associated protein Bap. Domain identification was performed with the InterPro71 and NCBI-CDD72 databases: MSCRAMM is the acronym for “microbial surface components recognizing adhesive matrix molecules”, which are adhesin proteins that mediate their attachment to surfaces73. Cadherin repeat-like motifs are putative Ca2+ binding domains74. Putative Ig domains are repeats found in several haemagglutinins and other cell surface proteins75. Polycystin cation channel protein is a putative Ca2+-permeable nonselective cation channel76. Location of the mutations present in bap of S. epidermidis S-1 and S-3 are shown. c Qualitative comparison of bacterial cell attachment to polystyrene in a micro-titer plate. The strains B. subtilis (B), and S. epidermidis wild type (S-WT) and S-3 strains were incubated in CDM supplemented with varying concentrations of Ca2+ (0, 5, and 10 mM), at 37 °C for 24 h. The experiment was performed in quadruplicates, and representative images are shown. d, Quantitative measurements of bacterial cell attachment (x-axis indicates biofilm growth) to polystyrene in a micro-titer plate. The strains B. subtilis (B), and S. epidermidis wild type (S-WT) and S-3 strains were incubated in CDM supplemented with varying concentrations of Ca2+ (0, 5, and 10 mM), at 37 °C for 24 h. Data are presented as mean ± S.D. Error bars represent standard deviation (SD) of the mean values of four experiments.

Since Bap proteins are responsible for cell-to-cell attachment, and potentially contribute to biofilm formation, we evaluated the attachment of cells of S. epidermidis wild type and S-3 strains to polystyrene plates in CDM supplemented with Ca2+. We performed a biofilm assay based on crystal violate (CV) in a qualitative (Fig. 6c) and quantitative (Fig. 6d) way, and used B. subtilis to compare the biofilm potential of the S. epidermidis strains. Figure 6c, d show that cells of S. epidermidis S-3 are affected by the presence of Ca2+, compared to the wild-type cells (S-WT), which show the same attachment properties when Ca2+ is present. Interestingly, the B. subtilis biofilm is strongly affected by the presence of Ca2+. The effects of Ca2+ on colony biofilms of B. subtilis have been previously studied, colony expansion is observed at low concentrations of calcium ions and a mechanism where Ca2+ modifies the amphiphilic properties of surfactin is proposed49.

Furthermore, in a preliminary study between several B. subtilis and S. epidermidis strains, we observed that B. subtilis does not develop motility towards a S. epidermidis Bap negative strain (Fig. S8). To further confirm this observation, we collected a bacterial supernatant of the S. epidermidis Bap negative strain and tested the B. subtilis motility as described above. Fig. S9 shows that only the S. epidermidis S-WT supernatant (Bap positive) triggers the B. subtilis motility. This result further supports a model where the Bap proteins are responsible of promoting B. subtilis motility.

Since EDTA is a calcium-chelating agent, we attempted to evaluate the interaction between B. subtilis and S. epidermidis in CDM-agar plates supplemented with EDTA. To this end, we used CDM containing 2.5 and 0.25 mM EDTA. Fig. S10 shows that EDTA strongly affects the B. subtilis growth. B. subtilis is unable to grow in the presence of EDTA 2.5 mM, and even at lower EDTA concentration (0.25 mM), where it is able to grow, it is unable to produce chlorotetain and motility. In addition, Fig. S10b shows that the S. epidermidis WT colony expansion is higher than the S-3 mutant in the presence of EDTA 0.25 mM. Since the S-3 strain has several mutations in the calcium-binding domain of the Bap protein, we speculate that the phenotype of lower colony expansion is related to the Bap protein and its role in cell-to-cell attachment. A deep biochemical analysis of the Bap protein in the S-1 and S-3 strains to investigate the molecular mechanism involved in the calcium binding or sensing should be undertaken to further corroborate the mechanism.

Together, our data suggest that the mutations in the Bap protein of S. epidermidis (S-1 and S-3 strains) potentially affect the cell-to-cell attachment and cell aggregation via Ca2+ sensing (see Fig. S4). Since S. epidermidis mutants are unable to promote motility in B. subtilis, and low concentrations of Ca2+ trigger colony expansion in B. subtilis49, we propose that the B. subtilis sliding occurs in response to the low availability of Ca2+ ions, which are sequestered by Bap proteins in the proximity of the S. epidermidis colony.


Bacteria commonly live in densely populated environments, where competition for nutrients and space is crucial10. The skin is one of these dense environments, where bacterial interactions occur to maintain a balance, and thus determine the composition of our skin microbiota50. We use B. subtilis and S. epidermidis to study whether these bacteria are able to establish a type of specific bacterial interaction. B. subtilis is recognized as an important protective bacterium of our skin16 and S. epidermidis is the most abundant member of the skin microbiota51. Our study reveals an interaction between these bacteria based on chlorotetain production and development of B. subtilis motile cells. Figure 7 shows a proposed model of this interaction, where the first response from B. subtilis colonies (24 h of incubation) is characterized by chlorotetain production, which results in partial degradation of the S. epidermidis colony. Previous studies suggest that bacilysin has other cellular functions beyond its antimicrobial activity, for instance bacilysin negative strains are defective in sporulation or germination/outgrowth52. In addition, bacilysin is highly produced during starvation stress30. Thus, B. subtilis might benefit of bacilysin (or chlorotetain) production, when growing in poor-nutrient niches, in two ways: regulation of cellular processes and killing competitors. These observations might explain why to utilize a very simple (dipeptide) antimicrobial instead of others to conquer a nutrient-limited environment. The second response involves an emerging B. subtilis subpopulation with sliding motility. Previous studies have demonstrated the capacity of B. subtilis to engulf other bacterial species31,53,54. We propose that in our study, this motility occurs as a response to the low Ca2+ levels in the environment due to the Ca2+ binding to the biofilm-associated protein Bap within the S. epidermidis colony and its surroundings. We propose that this spreading property by B. subtilis is a niche conquering strategy to expand its bacterial colony and limit the growth of other species.

Fig. 7: Proposed model of interaction between S. epidermidis and B. subtilis.

Bacterial colonies are able to interact at a close proximity. B. subtilis cells (rod-shaped bacteria in green) attack the neighbor colony of S. epidermidis (spherical-shaped bacteria in yellow) by producing chlorotetain (indicated with small dark green dots) during the first 24 h of incubation. S. epidermidis cells located in the diffusion zone of chlorotetain take the chlorotetain molecules up, and the release of L-anticapsin by chlorotetain hydrolyzation results in bacterial death41. However, cells in the periphery of the S. epidermidis colony remain unaffected, are able to develop the characteristic cell-to-cell attachment via biofilm-associated proteins (Bap; indicated with small orange dots). The Bap proteins require Ca2+ ions to acquire a proper folding and become functional, these proteins also mediate cell attachment to surfaces47,77. After 36 to 76 h incubation, the depletion of Ca2+ in the surroundings of the S. epidermidis colony triggers B. subtilis motility. A subpopulation of B. subtilis cells emerges, and utilizes sliding motility to reach the S. epidermidis colony. The B. subtilis engulf the remaining S. epidermidis colony, where the presence of Bap might facilitate the B. subtilis motility. Since high cell densities of S. epidermidis are resistant to chlorotetain, we speculate that the initial unaffected cells reach high cell densities and form biofilms structures, and thus, these cells tolerate the chlorotetain concentrations once the engulfment occurs.

Bacterial interactions are shaped by several factors, for instance by the cell density and the proximity between cells55. In our study, the interactions between B. subtilis and S. epidermidis colonies are indeed affected by the initial cell density. For instance, we observed that the lower the S. epidermidis initial cell densities, the higher the colony degradation (Fig. S11). This effect can be explained by the fact that at low S. epidermidis cell densities, chlorotetain is quickly produced by B. subtilis (present at higher cell densities), then it accumulates in the growth medium and immediately kills the low number of S. epidermidis cells.

The avoidance of conflicts and fights is a common strategy to survive between animals56,57,58. Here, we uncover an interaction between two microorganisms that resembles examples of the conflicts observed between higher organisms, for instance when an animal backs down if faced with another animal in competition. In this case study, our data suggest that S. epidermidis is actually playing a role in the interaction with B. subtilis by limiting the incoming attacks, e.g., it develops resistance to chlorotetain and mutations in the bap gene arises, which results in abolishment of the B. subtilis invasion of its colony. This strategy results in an effective way to allow S. epidermidis to survive. We observed that S. epidermidis resistant colonies show lower growth rate and reach lower cell densities compared to the wild type (Fig. S12). Thus, the resulting genetic mutations on the dtpT and bap genes lower the S. epidermidis fitness probably because of their impact on essential processes such as the nutrient uptake (via DtpT), and cell-to-cell adhesion (via Bap). Furthermore, as mentioned above, cell density also plays an important role in this interaction. Thus, the unaffected S. epidermidis cells (initially at a far distance from the B. subtilis colony), might not develop chlorotetain resistance, but are able to quickly grow and reach a high cell density, becoming a bacterial population able to tolerate high chlorotetain concentrations.

This study sheds light on how microbial communities define their territory in certain microenvironments of our skin, where many other bacteria live. Notably, B. subtilis is able to produce a plethora of antimicrobial compounds, which show activity against diverse bacteria and fungi14,59. For instance B. subtilis produces bacillomycin, an antibiotic with antifungal activity against all the important dermatophytes and systemic fungi60. Likewise S. epidermidis is able to produce peptides to inhibit Staphylococcus aureus and Streptococcus pyogenes2.

The skin microbiota is composed of many other different species of bacteria2,3. Thus, it is interesting to speculate about different interaction scenarios between these bacteria. Our study shows how bacteria respond locally to the secreted products of others, for instance the S. epidermidis resistance response when inhibitory molecules are in the environment. In addition, species of bacteria are known to colonize specific microenvironments of our skin, based on different factors such as pH, nutrients, or humidity61. Accordingly, specific bacterial competition strategies appear to be an important factor that defines which bacteria colonize a specific microenvironment of our skin.


Bacterial strains and growth conditions

All the bacterial strains used for this study are listed in the Supplementary Table 1. Experiments were performed with Bacillus subtilis 168, and Staphylococcus epidermidis JH (wild type). Staphylococcus epidermidis JH was isolated from human skin in Groningen, The Netherlands, by using an inoculation loop, passing it onto the surface of a human arm, and then streaking an M17-agar plate. A colony with beige color was obtained after 24 h incubation at 37 °C. The colony was again streaked out on an M17-agar plate to ensure the isolation of a single bacterium. Initially, the sequence analysis of 16S rRNA gene was performed using the BLAST program to identify this bacterium as Staphylococcus epidermidis62. Confirmation of the taxonomic assignment was performed by genomic DNA sequencing (see Genome sequencing).

B. subtilis, S. epidermidis, C. acnes, S. thermophilus cells were grown at 37 °C in chemically defined medium (CDM)63, supplemented with glucose (Sigma-Aldrich) 0.5% (w/v). CDM contained 49.6 mM NaCl, 20.1 mM Na2HPO4, 20.2 mM KH2PO4, 9.7 μM (±)-α-lipoic acid, 2.10 μM D-pantothenic acid, 8.12 μM nicotinic acid, 0.41 μM biotin, 4.91 μM pyridoxal hydrochloride, 4.86 μM pyridoxine hydrochloride, 2.96 μM thiamine hydrochloride, 0.24 μM (NH4)6Mo7O24, CaCl2 20.4 μM, 1.07 μM CoSO4, 1.20 μM CuSO4, 1.04 μM ZnSO4, 20.12 μM FeCl3, 1.46 mM L-alanine, 1.40 mM L-arginine, 0.61 mM L-asparagine, 1.03 mM L-aspartic acid, 0.35 mM L-cysteine, 0.66 mM L-glutamic acid, 0.66 mM L-glutamine, 0.39 mM glycine, 0.16 mM L-histidine, 0.63 mM L-isoleucine, 0.89 mM L-leucine, 1.02 mM L-lysine, 0.27 mM L-methionine, 0.39 mM L-phenylalanine, 3.58 mM L-proline, 1.64 mM L-serine, 0.57 mM L-threonine, 0.18 mM L-tryptophan, 2.76 mM L-tyrosine and 0.73 mM L-valine. GM17-agar or CDM-agar plates were prepared by adding agar 1.5% (w/v) and glucose to M17 or CDM, respectively. When necessary, culture media was supplemented with erythromycin 5 µg mL−1, chloramphenicol 5 µg mL−1, kanamycin 10 µg mL−1 or spectinomycin 100 µg mL−1.

Lactococcus lactis cells were grown at 30 °C in M17 broth (DifcoTM BD, NJ, USA) or in CDM, supplemented with glucose (Sigma-Aldrich) 0.5% (w/v).

For microscopy experiments or plate-reader assays, bacterial strains were grown in CDM with glucose 0.5% (w/v) and collected by centrifugation from exponential growth cultures (optical density of 0.4 at 600 nm) and washed three times with phosphate-buffered saline (PBS) solution (pH 7.2) containing: 15.44 µM KH2PO4, 1.55 mM NaCl and 27.09 µM Na2HPO4.

DNA techniques and oligonucleotides

DNA amplifications by PCR were performed using a PCR mix containing Phusion HF Buffer (Thermo Fisher Scientific Inc., MA, USA), 2.5 mM dNTPs mix, Phusion HF DNA polymerase (Thermo Fisher Scientific Inc., MA, USA), primers (0.5 μM each), and 50 ng of S. epidermidis JH chromosomal DNA as template. Oligonucleotides (Supplementary Table 2) were purchased from Biolegio (Nijmegen, The Netherlands). PCRs were performed in an Eppendorf thermal cycler (Eppendorf, Hamburg, Germany). The 16 s rRNA was amplified by 35 cycles of denaturation (98 °C for 30 s), annealing (5 °C or more, lower than Tm for 30 s), and extension (70 °C for 1 min per 1 Kbp). Amplifications were confirmed by 1% (w/v) agarose gel electrophoresis method. PCR products were isolated and cleaned-up with a high pure plasmid isolation kit (Roche Applied Science, Mannheim, Germany), according to the protocol of the manufacturer. DNA sequences were obtained by sequencing of the PCR fragments in the genomic region of interest (Macrogen Europe, Amsterdam, The Netherlands).

Interaction assay

Bacterial interaction assays were performed on CDM-agar plates. B. subtilis and S. epidermidis cells were grown overnight in CDM and washed three times with PBS. The optical density at 600 nm of each bacterial growth was adjusted to 0.4. A volume of 5 μL of each bacterial suspension was spotted on CDM-agar plates at different distances and incubated at 37 °C.

To test swarming, swimming and sliding motility in B. subtilis, CDM-agar plates were prepared with different agar concentrations: 0.8, 1, 1.5 and 2% (w/v).

Microscopy observations

Interaction between colonies of B. subtilis and S. epidermidis lactis was detected using an Olympus MVX20 macro zoom fluorescence microscope equipped with a PreciseExcite light-emitting diode (LED) fluorescence illumination (470 nm), GFP filter set (excitation 460/480 nm and emission 495/540 nm). Bright-field and fluorescent images were acquired with an Olympus XM10 monochrome camera (Olympus Co., Tokyo, Japan).

DNA sequencing

A single colony S. epidermidis JH (wild type strain) growing on a CDM-agar plate was selected and grown as standing culture in 5 mL of CDM broth, supplemented with 0.5% (w/v) glucose, and incubated overnight at 37 °C. Cells from the bacterial culture were collected by centrifugation at 6000×g for 3 min in a Microfuge 16 centrifuge (Beckman Coulter, Woerden, The Netherlands). Genomic DNA was isolated with a GenElute bacterial genome DNA kit (Sigma-Aldrich, Munich, Germany) according to the manufacturer’s instructions. The resulting genomic DNA was used as template to perform PCRs. The 16S rRNA gene was amplified by colony PCR using the oligonucleotides 27 F and 1492 R (see Supplementary Table 2). The DNA sequences were analyzed with BLAST program62.

In addition, the genomic DNA of the S. epidermidis mutant strains (S-1 and S-3) was isolated as described above. To this end, all the staphylococci genomes (wild type, S-1 and S-3) were paired-end sequenced at the Beijing Genomics Institute (BGI, Copenhagen N, Denmark) on a BGISEQ-500 platform. A total of 5 million paired-end reads (150 bp) were generated. FastQC version 0.11.564 was used to examine the quality of the reads. Taxonomic assignment of reads was performed with Kraken 2.0.765. The Rapid Annotations using Subsystems Technology (RAST) server66 was used to annotate the genomes. Identification of mutations was performed with Breseq67, using the S. epidermidis JH data as a reference sequence (JAAUOD000000000).

Antimicrobial assay

Each B. subtilis strain was inoculated in 100 mL of CDM and grown at 37 °C. Cells were harvested by centrifugation at 6000×g for 15 min. The supernatants were transferred into a clean tube, filtered through nitrocellulose Whatman filters (0.45 and 0.2 µm) and stored at 4 °C for subsequent analysis. Antimicrobial activity of 150 µL of the bacterial supernatants was assessed on CDM-agar plates, using S. epidermidis wild-type strain as indicator strain.

Chlorotetain identification

UHPLC-M analysis was performed using a Dionex Ultimate 3000 UHPLC chromatographic system combined with a Q Exactive mass spectrometer (both from Thermo Fisher Scientific) fitted with a heated electrospray source operated in the positive ion mode. UHPLC separation was performed on a Kinetex EVO C18, 2.6 µm, 2.1 mm × 150 mm column (Phenomenex, Maarsen, The Netherlands). The column was kept at 50 ± 0.1 °C during analysis. Mobile phases were A: 100% water, 0.1% formic acid, and B: 100% ACN and 0.1% formic acid. The injection volume for all separations was 10 µL. Chromatographic elution was achieved under gradient conditions with a flow rate of 400 µL/min. Elution started with an isocratic step of 1.0 min at 1% B, followed by a linear gradient from 1 to 95% B (1.0–10.0 min. These conditions were maintained for 2 min before returning to 1% B in 0.03 min and equilibration at start conditions for 3 min. The total runtime was 15 min. The Q Exactive mass spectrometer was operated with a capillary voltage of 3.50 kV. The capillary temperature was set at 275 °C, and auxiliary gas temperature at 350 °C. The sheath gas pressure, auxiliary gas pressure and sweep gas flow rate were set at 50, 10, and one arbitrary units, respectively, with nitrogen gas. Spectra were recorded from 100 to 750 m/z at a resolution of 70000@mz200. Xcalibur 4.1 was used for data processing.

Motility assay

B. subtilis motility was assessed on CDM-agar plates. One fifty microliter of filtered S. epidermidis supernatants were located in the center of the CDM-agar plates, and 5 µL of B. subtilis was spotted on the plates around the S. epidermidis supernatant in a spiral configuration to evaluate motility at different diffusion distances. A plate with 150 µL of CDM instead of bacterial supernatant was used as a control. CDM-agar plates were incubated 24 h at 37 °C.

Disc assay

Sterile 5.5 mm diameter filter paper discs were placed on CDM-agar plates. Two discs were used per plate. Twenty microliters of the bacterial supernatant or control medium (CDM) were placed on the center of the discs, and the plates were dried for 5 min by keeping them open in a laminar flow cabinet. Five microliters of an overnight culture of the B. subtilis strain was then inoculated at different distances to the edge of the discs. The plates were incubated at 37 °C for 24 h. After the incubation period, snapshots were taken with an imaging system ChemiDoc XRS (Bio-Rad).

Intracellular and extracelular contents

Each S. epidermidis strain (S-WT, S-1, S-3) was inoculated in 20 mL of CDM and grown overnight at 37 °C. Cells were harvested by centrifugation at 6000×g for 15 min. The supernatants were transferred into a clean tube, filtered through nitrocellulose Whatman filters (0.45 and 0.2 µm) and stored at 4 °C for subsequent analysis. Motility activity of B. subtilis was tested with 150 µL of the bacterial supernatants (extracellular) on CDM-agar plates. For intracellular content, the bacterial pellet was resuspended in CDM (cell suspension) and sonicated on ice for 10 min using a VCX 130 Sonicator with cycle 10 s ON and 10 s OFF. Cell debris was removed by centrifugation at 6000×g for 15 min at 4 °C. The supernatant was collected and filtered through a 0.45 μm filter.

Biofilm assays

We employed a biofilm formation method using the dye crystal violet (CV)68. Bacterial strains were grown overnight in CDM supplemented with different calcium concentrations (1, 5, and 10 mM). Grown was performed in 100 µL per well in a 96-well plate. We used four replicates per treatment. The plate was incubated 26 h at 37 °C. After incubation, bacterial cultures were removed from the wells and rinsed two times with deionized water to remove unattached cells. Next, 125 μL of a 0.1% solution of crystal violet in water to each well of the micro-titer plate was added. The micro-titer plate was incubated at room temperature for 15 min. Then, it was rinsed three times with water, and dried by incubation at 37 °C for 2 h. For qualitative assays, the wells were photographed. Qualitative measurements were performed as follows. One twenty five microliter of 30% acetic acid in water to each well were added to solubilize the CV. The micro-titer plate was incubated at room temperature for 15 min. One twenty five microliter of the solubilized CV was transferred to a new flat-bottomed micro-titer plate. Absorbance measurements were performed in a plate reader at 550 nm using 30% acetic acid in water as the blank.

Plate-reader assays

Cultures of S. epidermidis and B. subtilis were grown and prepared as described above. For growth measurements, cells were diluted 1:20 in CDM. The growth was recorded in 0.2 mL cultures in 96-well micro-titer plates and monitored by using a micro-titer plate reader VarioSkan (Thermo Fisher Scientific Inc., MA, USA). Growth was recorded with measurements of the optical density at 600 nm (OD600) every 10 min for 24 h. Values were corrected for the background value of the corresponding medium used for growth.

Flow cytometry

B. subtilis strains were grown for interaction assays with S. epidermidis in CDM as described above. Biofilms were scraped from the CDM-agar surface and resuspended in 800 µL PBS. The biofilms were disrupted by repetitive passes through a 23 G needle as reported in a previous study69. Cells were subjected to a mild sonication to obtain a preparation of single cells as described70. A threshold for the FSC and SCC parameters was set (200 in both) in the FACS Canto flow cytometer (BD Biosciences, CA, USA) to remove all the events that do not correspond to cells. The GFP-signal at all the measured cells was recorded in 30,000 events and used for downstream analysis (named ungated events in the corresponding figures). GFP-signal measurements were obtained with a FACS Canto flow cytometer (BD Biosciences, CA, USA) using a 488 nm argon laser. Raw data was collected using the FACSDiva Software 5.0.3 (BD Biosciences). And the FlowJo software was used for data analysis (

Statistics and reproducibility

Statistical analyses were performed using Prism 6.01 (GraphPad software All experiments were repeated independently at least three times. All micrographs, including small insets, show representative images from three independent replicate experiments.


Alignments and sequences identities were determined by using BLAST62 and RAST66, using the full-length protein or DNA sequences. Protein domains were identified with the InterPro and NCDI-CDC databases. Identification of mutations was performed with breseq version 0.32.167.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

The S. epidermidis JH, S-1 and S-3 genomes were submitted to NCBI and are publicly available in the following accession codes: JAAUOD000000000 (JH; WT), JABTXG000000000 (S-1) and JABTXF000000000 (S-3). Data supporting the findings of this work are available within the paper and its Supplementary Information files. All other data are available from the corresponding author on request.


  1. 1.

    Belkaid, Y. & Segre, J. A. Dialogue between skin microbiota and immunity. Science346, 954–959 (2014).

    CAS  PubMed  Google Scholar 

  2. 2.

    Cogen, A. L., Nizet, V. & Gallo, R. L. Skin microbiota: a source of disease or defence? Br. J. Dermatol.158, 442–455 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Kumar, A. & Chordia, N. Role of microbes in human health. Appl. Microbiol. Open Access.13, 1–3 (2017).

    Google Scholar 

  4. 4.

    Radeck, J. et al. Anatomy of the bacitracin resistance network in Bacillus subtilis. Mol. Microbiol.100, 607–620 (2016).

    CAS  PubMed  Google Scholar 

  5. 5.

    Grice, E. A. & Segre, J. A. The skin microbiome. Nat. Rev. Microbiol.16, 143–155 (2011).

    Google Scholar 

  6. 6.

    Grice, E. A. The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease. Semin. Cutan. Med. Surg.33, 98–103 (2014).

    PubMed  PubMed Central  Google Scholar 

  7. 7.

    Gonzalez, D. J. et al. Microbial competition between Bacillus subtilis and Staphylococcus aureus monitored by imaging mass spectrometry. Microbiology157, 2485–2492 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Hibbing, M. E., Fuqua, C., Parsek, M. R. & Peterson, S. B. Bacterial competition: surviving and thriving in the microbial jungle. Nat. Rev. Microbiol.8, 15–25 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Granato, E. T., Meiller-Legrand, T. A. & Foster, K. R. The evolution and ecology of bacterial warfare. Curr. Biol.29, R521–R537 (2019).

    CAS  PubMed  Google Scholar 

  10. 10.

    Stubbendieck, R. M. & Straight, P. D. Multifaceted interfaces of bacterial competition. J. Bacteriol.198, 2145–2155 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Hegarty, J. W., Guinane, C. M., Ross, R. P., Hill, C. & Cotter, P. D. Bacteriocin production: a relatively unharnessed probiotic trait? F1000Research.5, 2587 (2016).

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Schluter, J., Nadell, C. D., Bassler, B. L. & Foster, K. R. Adhesion as a weapon in microbial competition. ISME J.9, 139–149 (2015).

    CAS  PubMed  Google Scholar 

  13. 13.

    Costa, O. Y. A., Raaijmakers, J. M. & Kuramae, E. E. Microbial extracellular polymeric substances: ecological function and impact on soil aggregation. Front. Microbiol.9, 1636 (2018).

    PubMed  PubMed Central  Google Scholar 

  14. 14.

    Caulier, S. et al. Overview of the antimicrobial compounds produced by members of the Bacillus subtilis group. Front. Microbiol.10, 302 (2019).

    PubMed  PubMed Central  Google Scholar 

  15. 15.

    Serra, C. R., Earl, A. M., Barbosa, T. M., Kolter, R. & Henriques, A. O. Sporulation during growth in a gut isolate of Bacillus subtilis. J. Bacteriol.196, 4184–4196 (2014).

    PubMed  PubMed Central  Google Scholar 

  16. 16.

    Petruk, G., Donadio, G., Lanzilli, M., Isticato, R. & Monti, D. M. Alternative use of Bacillus subtilis spores: protection against environmental oxidative stress in human normal keratinocytes. Sci. Rep.8, 1745 (2018).

    PubMed  PubMed Central  Google Scholar 

  17. 17.

    Wilson, M. The skin and its indigenous microbiota. In Microbial Inhabitants of Humans: Their Ecology and Role in Health and Disease. 51–106 (Cambridge University Press, Cambridge, 2004).

  18. 18.

    Ara, K. et al. Foot odor due to microbial metabolism and its control. Can. J. Microbiol.52, 357–364 (2006).

    CAS  PubMed  Google Scholar 

  19. 19.

    Otto, M. Staphylococcus epidermidis—the ‘accidental’ pathogen. Nat. Rev. Microbiol.7, 555–567 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Schoenfelder, S. M. K. et al. Success through diversity—how Staphylococcus epidermidis establishes as a nosocomial pathogen. Int. J. Med. Microbiol.300, 380–386 (2010).

    PubMed  Google Scholar 

  21. 21.

    Oliveira, N. M. et al. Biofilm formation as a response to ecological competition. PLoS Biol.13, e1002191 (2015).

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Lopez, D., Vlamakis, H. & Kolter, R. Generation of multiple cell types in Bacillus subtilis. FEMS Microbiol. Rev.33, 152–163 (2009).

    CAS  PubMed  Google Scholar 

  23. 23.

    Calvio, C. et al. Swarming differentiation and swimming motility in Bacillus subtilis are controlled by swrA, a newly identified dicistronic operon. J. Bacteriol.187, 5356–5366 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    van Gestel, J., Vlamakis, H. & Kolter, R. From cell differentiation to cell collectives: Bacillus subtilis uses division of labor to migrate. PLoS Biol.13, e1002141 (2015).

    PubMed  PubMed Central  Google Scholar 

  25. 25.

    Kinsinger, R. F., Shirk, M. C. & Fall, R. Rapid surface motility in Bacillus subtilis is dependent on extracellular surfactin and potassium ion. J. Bacteriol.185, 5627–5631 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Kinsinger, R. F., Kearns, D. B., Hale, M. & Fall, R. Genetic requirements for potassium ion-dependent colony spreading in Bacillus subtilis. J. Bacteriol.187, 8462–8469 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Ogran, A. et al. The plant host induces antibiotic production to select the most-beneficial colonizers. Appl. Environ. Microbiol.85, e00512–e00519 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov.12, 371–387 (2013).

    CAS  PubMed  Google Scholar 

  29. 29.

    Stubbendieck, R. M. & Straight, P. D. Escape from lethal bacterial competition through coupled activation of antibiotic resistance and a mobilized subpopulation. PLoS Genet.11, e1005722 (2015).

    PubMed  PubMed Central  Google Scholar 

  30. 30.

    Özcengiz, G. & Öğülür, I. Biochemistry, genetics and regulation of bacilysin biosynthesis and its significance more than an antibiotic. N. Biotechnol.32, 612–619 (2015).

    PubMed  Google Scholar 

  31. 31.

    Rosenberg, G. et al. Not so simple, not so subtle: the interspecies competition between Bacillus simplex and Bacillus subtilis and its impact on the evolution of biofilms. npj Biofilms Microbiomes.2, 15027 (2016).

    PubMed  PubMed Central  Google Scholar 

  32. 32.

    Kearns, D. B. A field guide to bacterial swarming motility. Nat. Rev. Microbiol.8, 634–644 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Veening, J. W. et al. Transient heterogeneity in extracellular protease production by Bacillus subtilis. Mol. Syst. Biol.4, 184 (2008).

    PubMed  PubMed Central  Google Scholar 

  34. 34.

    Amati, G., Bisicchia, P. & Galizzi, A. DegU-P represses expression of the motility fla-che operon in Bacillus subtilis. J. Bacteriol.186, 6003–6014 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Verhamme, D. T., Murray, E. J. & Stanley-Wall, N. R. DegU and Spo0A jointly control transcription of two loci required for complex colony development by Bacillus subtilis. J. Bacteriol.191, 100–108 (2009).

    CAS  PubMed  Google Scholar 

  36. 36.

    Marlow, V. L. et al. Phosphorylated DegU manipulates cell fate differentiation in the Bacillus subtilis biofilm. J. Bacteriol.196, 16–27 (2014).

    PubMed  PubMed Central  Google Scholar 

  37. 37.

    Newman, J. A., Rodrigues, C. & Lewis, R. J. Molecular basis of the activity of SinR Protein, the master regulator of biofilm formation in Bacillus subtilis. J. Biol. Chem.288, 10766–10778 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Vlamakis, H., Chai, Y., Beauregard, P., Losick, R. & Kolter, R. Sticking together: building a biofilm the Bacillus subtilis way. Nat. Rev. Microbiol.11, 157–168 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Kearns, D. B., Chu, F., Branda, S. S., Kolter, R. & Losick, R. A master regulator for biofilm formation by Bacillus subtilis. Mol. Microbiol.55, 739–749 (2005).

    CAS  PubMed  Google Scholar 

  40. 40.

    Wu, S. C. et al. Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: Effects of molecular chaperones and a wall-bound protease on antibody fragment production. Appl. Environ. Microbiol.68, 3261–3269 (2002).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Kenig, M. & Abraham, E. P. Antimicrobial activities and antagonists of bacilysin and anticapsin. J. Gen. Microbiol.94, 37–45 (1976).

    CAS  PubMed  Google Scholar 

  42. 42.

    Ertekin, O. et al. Analysis of a bac operon-silenced strain suggests pleiotropic effects of bacilysin in Bacillus subtilis. J. Microbiol.58, 297–313 (2020).

    CAS  PubMed  Google Scholar 

  43. 43.

    Mariappan, A., Makarewicz, O., Chen, X. H. & Borriss, R. Two-component response regulator DegU controls the expression of bacilysin in plant-growth-promoting bacterium Bacillus amyloliquefaciens FZB42. J. Mol. Microbiol. Biotechnol.22, 114–125 (2012).

    CAS  PubMed  Google Scholar 

  44. 44.

    Verhamme, D. T., Kiley, T. B. & Stanley-Wall, N. R. DegU co-ordinates multicellular behaviour exhibited by Bacillus subtilis. Mol. Microbiol.65, 554–568 (2007).

    CAS  PubMed  Google Scholar 

  45. 45.

    Rajavel, M., Mitra, A. & Gopal, B. Role of Bacillus subtilis BacB in the synthesis of bacilysin. J. Biol. Chem.284, 31882–31892 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Dahl, M. K., Msadek, T., Kunst, F. & Rapoport, G. Mutational analysis of the Bacillus subtilis DegU regulator and its phosphorylation by the DegS protein kinase. J. Bacteriol.173, 2539–2347 (1991).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. 47.

    Lasa, I. & Penadés, J. R. Bap: a family of surface proteins involved in biofilm formation. Res. Microbiol.157, 99–107 (2006).

    CAS  PubMed  Google Scholar 

  48. 48.

    Perez, T. D. & Nelson, W. J. Cadherin adhesion: mechanisms and molecular interactions. Handb. Exp. Pharmacol.165, 3–21 (2004).

    CAS  Google Scholar 

  49. 49.

    Mhatre, E. et al. Presence of calcium lowers the expansion of Bacillus subtilis colony biofilms. Microorganisms5, 7 (2017).

    PubMed Central  Google Scholar 

  50. 50.

    Chiller, K., Selkin, B. A. & Murakawa, G. J. Skin microflora and bacterial infections of the skin. J. Investig. Dermatol. Symp. Proc.6, 170–174 (2001).

    CAS  PubMed  Google Scholar 

  51. 51.

    Claudel, J. P. et al. Staphylococcus epidermidis: a potential new player in the physiopathology of acne? Dermatology235, 287–294 (2019).

    PubMed  Google Scholar 

  52. 52.

    Hilton, M. D., Alaeddinoglu, N. G. & Demain, A. L. Bacillus subtilis mutant deficient in the ability to produce the dipeptide antibiotic bacilysin: isolation and mapping of the mutation. J. Bacteriol.170, 1018–1020 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Steinberg, N. et al. The extracellular matrix protein TasA is a developmental cue that maintains a motile subpopulation within Bacillus subtilis biofilms. Sci. Signal.13, eaaw8905 (2020).

    CAS  PubMed  Google Scholar 

  54. 54.

    Gallegos-Monterrosa, R. et al. Lysinibacillus fusiformis M5 induces increased complexity in Bacillus subtilis 168 colony biofilms via hypoxanthine. J. Bacteriol.199, e00204–e00217 (2017).

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Tecon, R., Ebrahimi, A., Kleyer, H., Levi, S. E. & Or, D. Cell-to-cell bacterial interactions promoted by drier conditions on soil surfaces. Proc. Natl Acad. Sci. USA115, 9791–9796 (2018).

    CAS  PubMed  Google Scholar 

  56. 56.

    Rosier, R. L. & Langkilde, T. Behavior under risk: how animals avoid becoming dinner. Nat. Educ. Knowl.2, 8 (2011).

    Google Scholar 

  57. 57.

    Arnott, G. & Elwood, R. W. Assessment of fighting ability in animal contests. Anim. Behav.77, 991–1004 (2009).

    Google Scholar 

  58. 58.

    Johnson, D. D. P. & Toft, M. D. Grounds for war: the evolution of territorial conflict. Int. Secur.38, 7–38 (2014).

    Google Scholar 

  59. 59.

    Zhao, X. & Kuipers, O. P. Identification and classification of known and putative antimicrobial compounds produced by a wide variety of Bacillales species. BMC Genomics.17, 882 (2016).

    PubMed  PubMed Central  Google Scholar 

  60. 60.

    Landy, M., Warren, G. H., Rosenmanm, S. B. & Colio, L. G. Bacillomycin: an antibiotic from Bacillus subtilis active against pathogenic fungi. Proc. Soc. Exp. Biol. Med.67, 539–541 (1948).

    CAS  PubMed  Google Scholar 

  61. 61.

    Li, X., Yuan, C., Xing, L. & Humbert, P. Topographical diversity of common skin microflora and its association with skin environment type: An observational study in Chinese women. Sci. Rep.7, 18046 (2017).

    PubMed  PubMed Central  Google Scholar 

  62. 62.

    Madden, T. The BLAST Sequence Analysis Tool. 2013 Mar 15. In: The NCBI Handbook [Internet]. 2nd edn. (National Center for Biotechnology Information (US), Bethesda, 2013).

  63. 63.

    Goel, A., Santos, F., de Vos, W. M., Teusink, B. & Molenaar, D. Standardized assay medium to measure Lactococcus lactis enzyme activities while mimicking intracellular conditions. Appl. Environ. Microbiol.78, 134–143 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  64. 64.

    Andrews, S. FastQC: a quality control tool for high throughput sequence data. (2010).

  65. 65.

    Wood, D. E. & Salzberg, S. L. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol.15, R46 (2014).

    PubMed  PubMed Central  Google Scholar 

  66. 66.

    Aziz, R. K. et al. The RAST Server: rapid annotations using subsystems technology. BMC Genom.9, 75 (2008).

    Google Scholar 

  67. 67.

    Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol.1151, 165–188 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  68. 68.

    O’Toole, G. A. Microtiter dish biofilm formation assay. J. Vis. Exp.47, 1–2 (2010).

    Google Scholar 

  69. 69.

    Vlamakis, H., Aguilar, C., Losick, R. & Kolter, R. Control of cell fate by the formation of an architecturally complex bacterial community. Genes Dev.22, 945–953 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  70. 70.

    Branda, S. S., Chu, F., Kearns, D. B., Losick, R. & Kolter, R. A major protein component of the Bacillus subtilis biofilm matrix. Mol. Microbiol.49, 1229–1328 (2006).

    Google Scholar 

  71. 71.

    Hunter, S. et al. InterPro: the integrative protein signature database. Nucleic Acids Res.37, D211–D215 (2009).

    CAS  PubMed  Google Scholar 

  72. 72.

    Marchler-Bauer, A. et al. CDD/SPARCLE: functional classification of proteins via subfamily domain architectures. Nucleic Acids Res.45, D200–D203 (2017).

    CAS  PubMed  Google Scholar 

  73. 73.

    Foster, T. J. The MSCRAMM family of cell-wall-anchored surface proteins of gram-positive Cocci. Trends Microbiol.27, 927–941 (2019).

    CAS  PubMed  Google Scholar 

  74. 74.

    Sotomayor, M. & Schulten, K. The allosteric role of the Ca2+ switch in adhesion and elasticity of C-cadherin. Biophys. J.94, 4621–4633 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  75. 75.

    Bentley, S. D. et al. Sequencing and analysis of the genome of the Whipple’s disease bacterium Tropheryma whipplei. Lancet361, 637–644 (2003).

    CAS  PubMed  Google Scholar 

  76. 76.

    Chen, X. Z. et al. Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature401, 383–386 (1999).

    CAS  PubMed  Google Scholar 

  77. 77.

    Cucarella, C. et al. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J. Bacteriol.183, 2888–2896 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references


We thank Anne de Jong (Department of Molecular Genetics, University of Groningen) for his help with sequences analysis. J.A.H.V. and O.P.K. were financed by the Netherlands Organization for Scientific Research (NWO), research program TTW (13858). L.Z. was financially supported by the China Scholarship Council (201606910037).

Author information




J.A.H.V. conceived the study. J.A.H.V. designed and carried out all the experiments. L.Z. performed sample preparations for UHPLC analysis and interpreted data. M.d.V. performed the UHPLC-M analyses and analyzed the data. J.A.H.V. and O.P.K. wrote the manuscript. O.P.K. provided supervision. All authors discussed the results and commented on the manuscript.

Corresponding author

Correspondence to Oscar P. Kuipers.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hernandez-Valdes, J.A., Zhou, L., de Vries, M.P. et al. Impact of spatial proximity on territoriality among human skin bacteria. npj Biofilms Microbiomes 6, 30 (2020).

Download citation


Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing